A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines “shy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though not always) associated with pharmacological dependence, which is manifested through the withdrawal symptoms during their discontinuation.”
